Skip to main content

Hamad Medical Corporation Opens Interim Translational Research Institute

Published 3/27/2014

Hamad Medical Corporation opened the Interim Translational Research Institute (iTRI) in March of 2014 in Doha, Qatar. Located in Hamad Bin Khalifa Medical City, the facility will support advanced biomedical research in genomics, cancer, cardiovascular diseases, diabetes, respiratory medicine, and neurosciences. The iTRI includes wet laboratories, a clinical studies unit, a conference center, and core labs for sample analysis and other services.